Bladder cancer laboratory findings

Bladder cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Bladder cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Electrocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Biopsy
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Bladder cancer laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Bladder cancer laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Bladder cancer laboratory findings
CDC on Bladder cancer laboratory findings
Bladder cancer laboratory findings in the news
Blogs on Bladder cancer laboratory findings
Directions to Hospitals Treating Bladder cancer
Risk calculators and risk factors for Bladder cancer laboratory findings

Steven C. Campbell, M.D., Ph.D.

Laboratory Findings

• Urinalysis

• Blood in the urine

• Urine cytology

• Presence of abnormal cells

• Tumour marker tests

• Bladder tumour–associated antigen (BTA)
• Nuclear matrix proteins (NMP)
• Mucin and carcinoembryonic antigen (CEA)

• Complete blood count

• Low red blood cell count

• Blood chemistry tests

• Elevated alkaline phosphatase